ProPhase Labs, Inc.
PRPH
$0.3513
$0.041113.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -80.65% | -94.65% | -89.09% | -79.54% | -71.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -80.65% | -94.65% | -89.09% | -79.54% | -71.48% |
| Cost of Revenue | -64.38% | -74.58% | -71.57% | -64.91% | -62.63% |
| Gross Profit | -100.96% | -115.74% | -105.77% | -91.23% | -77.98% |
| SG&A Expenses | 13.29% | -25.00% | -22.02% | -6.08% | -2.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.22% | -50.84% | -50.70% | -42.26% | -43.26% |
| Operating Income | -82.04% | -128.13% | -385.00% | -465.08% | -189.93% |
| Income Before Tax | -88.99% | -130.51% | -355.02% | -520.38% | -197.77% |
| Income Tax Expenses | 219.56% | -75.67% | -177.12% | -924.35% | -235.39% |
| Earnings from Continuing Operations | -202.35% | -161.14% | -493.40% | -455.75% | -188.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -217.98% | -164.97% | -502.61% | -461.92% | -190.89% |
| EBIT | -82.04% | -128.13% | -385.00% | -465.08% | -189.93% |
| EBITDA | -113.86% | -177.41% | -1,191.39% | -283.01% | -153.58% |
| EPS Basic | -168.47% | -144.53% | -464.41% | -420.87% | -181.28% |
| Normalized Basic EPS | -58.18% | -116.46% | -345.28% | -452.71% | -185.96% |
| EPS Diluted | -169.27% | -146.11% | -460.27% | -502.55% | -198.91% |
| Normalized Diluted EPS | -57.89% | -115.91% | -320.28% | -603.63% | -210.27% |
| Average Basic Shares Outstanding | 12.50% | 9.26% | 8.49% | 7.46% | 7.55% |
| Average Diluted Shares Outstanding | 10.37% | 7.16% | -0.12% | -6.17% | -7.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |